Delphi

May Mobility selects autonomous driving expert as COO

Retrieved on: 
Monday, November 28, 2022
Marketing, Female, Motorola, Toyota, ADAS, Infotainment, Business Insider, Engineering, University, Multimedia, Automotive News, Safety, Acquisition, Champaign County, Illinois, Traction, Intel, Transport, Advanced driver-assistance systems, Women in Tech, Mobility, EE Times, Automation, City, ANN, Chicago (franchise), AV, Woman, Mobileye, Business, Delphi, Management, Science

ANN ARBOR, Mich., Nov. 28, 2022 /PRNewswire/ -- May Mobility, a leader in the development and deployment of autonomous vehicle (AV) technology, today announced the appointment of Kathy Winter as its Chief Operating Officer. Winter brings nearly 30 years of engineering and automotive experience leading companies to significant revenue growth and product development worldwide, including more than ten years exclusively working on advancements in the autonomous driving sector. Winter will be focused on accelerating execution across the company, as well as developing key strategies and partnerships to help May scale on a global basis.

Key Points: 
  • Winter brings nearly 30 years of engineering and automotive experience leading companies to significant revenue growth and product development worldwide, including more than ten years exclusively working on advancements in the autonomous driving sector.
  • We're thrilled she is joining our executive team and we know Kathy will further propel May Mobility to the forefront of the industry, spurring investments and global growth."
  • Winter was responsible for establishing their Autonomous Vehicle Labs, global product strategy, roadmaps, P&L, and R&D for Intel's Advanced Driver Assist Systems (ADAS), Infotainment and Automated Driving businesses.
  • "I am delighted to join May Mobility and believe May's groundbreaking autonomous vehicle technology is poised to enable the cities of the future," said Winter.

AM Best Affirms Credit Ratings of Delphi Financial Group, Inc. and Its Subsidiaries

Retrieved on: 
Thursday, November 17, 2022
Banking, Professional Services, Insurance, Finance, Superior, Reliance, Tokio Marine, SSL, Environment, News, Credit, Long-Term Capital Management, ALL, DFG, Insurance, IR, ERM, AM Best, Revenue stream, Safety, Delphi, FSR, AM, DE, Risk, Risk management, Parental leave, Security (finance)

The outlook of these Credit Ratings (ratings) is stable.

Key Points: 
  • The outlook of these Credit Ratings (ratings) is stable.
  • Concurrently, AM Best has affirmed the Long Term ICR of a+ (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IR) of DFG.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings .
  • For information on the proper use of Bests Credit Ratings, Bests Performance Assessments, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments .

Approximately 80% of Consumers Would Pay with Points Online or In-Store if Given the Option, According to New Research from The Wise Marketer

Retrieved on: 
Thursday, November 17, 2022
Professional Services, Marketing, Advertising, Communications, Finance, Banking, Marketing, WMG, Consumer, News, Friction, Wise, Professional, Publishing, Research, Delphi, CLMP, Non-fungible token, Online shopping

The report examines consumers' attitudes toward traditional and emerging rewards redemption options, including the ability to pay with points (PwP), during a time of heightened inflation.

Key Points: 
  • The report examines consumers' attitudes toward traditional and emerging rewards redemption options, including the ability to pay with points (PwP), during a time of heightened inflation.
  • In addition, 80% of consumers said they would "top up" and use PwP with cash to complete a transaction.
  • When it comes to loyalty program motivators among consumers, 79% reported earning specific awards among their top three choices of desired reward program benefits.
  • The Wise Marketer on-line publication is the most widely read news source for customer engagement and loyalty marketers.

Delphi-MD Breakthrough diagnostic technology promises to reduce healthcare burden by detecting brain abnormalities prior to symptoms, at the point of care

Retrieved on: 
Monday, November 14, 2022
Health, Quality of life, Neurology, Technology, Cardiovascular disease, Neuro, Patient, Impact, Figure, Rehabilitation, UCLA, Physician, Behavior, Hospital, FDA, Entrepreneurship, Manisha Girotra, Delphi, World, Lancet, CEO, UCLA IMG Program, Brain, Diagnosis, AHA, Medical imaging, Stroke, Dementia

RAANANA, Israel, Nov. 14, 2022 /PRNewswire/ -- QuantalX developer of Delphi-MD, an "ECG" for the brain, showcases its brain health revolutionizing technology at the HLTH Las Vegas conference for the first time as part of its US commercialization efforts towards expected FDA breakthrough path clearance.

Key Points: 
  • For patients, an earlier diagnosis leads to an optimal care pathway, resulting in a positive, long-term effect on quality of life.
  • Recent estimations* show the financial burden of stroke and dementia care alone to exceed $550B/ year in the US alone.
  • "Making neuro-diagnosis accessible to everyone is game changing for brain health management"
    "I am very excited by QuantalX's Delphi-MD technology.
  • The Delphi-MD device solves current neurology diagnostic challenges through a direct neuro diagnosis, novel technology, revolutionizing brain health standard of care as we know it.

CreakyJoints Presents Multistakeholder Priorities for Research in Vaccine Uptake Among Adults with Autoimmune Disease at the American College of Rheumatology Convergence 2022

Retrieved on: 
Tuesday, November 8, 2022
Medical Supplies, Technology, Professional Services, Other Health, Health, Medical Devices, Research, Data Analytics, Mobile, Wireless, Science, Clinical Trials, Narrative, Systematic review, RA, Poster, Hospital, Friends, News, HSS, Physician, Patient, MD, Empowerment, Vaccine, ACR, Delphi, MSW, Patient-Centered Outcomes Research Institute, Disease, Rheumatoid arthritis, American College, Arthritis, PCORI, Infection, Medical Affairs Bureau, Policy, Education, American College of Rheumatology, Doctor of Philosophy, Hospital for Special Surgery, Mental health, Autoimmune disease, Family, Disease-modifying antirheumatic drug, Research, Risk, Safety, Vaccine hesitancy, Exercise, Social work, Severe acute respiratory syndrome coronavirus 2, Pharmaceutical industry, Medical device, Telehealth, Rheumatology, Hispanic

Thirty-three topics were narrowed down using a modified online Delphi process to thirteen topics rated as critical by at least 70 percent of stakeholders.

Key Points: 
  • Thirty-three topics were narrowed down using a modified online Delphi process to thirteen topics rated as critical by at least 70 percent of stakeholders.
  • Top topics identified for research included: vaccine effectiveness for adults with autoimmune disease, beliefs about vaccine safety among adults with autoimmune disease, and myths and misinformation about vaccines.
  • One of the 2022 accepted scientific posters, Home-Based Telehealth in Rheumatology: A Systematic Review & Narrative Synthesis, also shares patient perspectives on telemedicine delivery.
  • Scientific Posters by CreakyJoints at the ACR Convergence 2022:

SeaStar Medical’s Lead Product Candidate, the Selective Cytopheretic Device (SCD), Included in Consensus Statement for Pediatric Acute Kidney Injury in First Pediatric Acute Disease Quality Initiative (ADQI) Meeting

Retrieved on: 
Monday, November 7, 2022
Consensus, GLOBE, NASDAQ, Critical care, Pharmacology, Monocyte, Industry, SCD, Design history file, FDA, Patient, SEC, Form, Company, Dialysis, CRRT, Private Securities Litigation Reform Act, Mortality, Acute kidney injury, ICU, Delphi, Consensus decision-making, Chronic kidney disease, LMAO, Renal replacement therapy, Forward-looking statement, IL-6, Inflammation, Gaps, HDE, Humanitarian Device Exemption, Education, Nephrology, Epidemiology, Hemofiltration, Contraindication, Disease, CKD, Science, Biology, Solution, CKRT, Research, Neutrophil, AKI, Adult, Risk, SeaStar, Cytokine, Failure, Medicine, Pharmaceutical industry

DENVER, COLORADO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq:ICU), (“SeaStar Medical” or the “Company”), a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, today announced its Selective Cytopheretic Device (SCD) has been included in the Consensus Statement for pediatric acute kidney injury (AKI) as part of the first Pediatric Acute Disease Quality Initiative (pADQI) meeting. The outcome of the meeting, titled “Consensus-Based Recommendations on Priority Activities to Address Acute Kidney Injury in Children,” has been published in JAMA Network Open1.

Key Points: 
  • The outcome of the meeting, titled Consensus-Based Recommendations on Priority Activities to Address Acute Kidney Injury in Children , has been published in JAMA Network Open1.
  • The first pediatric ADQI convened in November 2021 to develop expert-driven pediatric specific recommendations on AKI.
  • Its primary aim was to identify the work priorities across the pediatric AKI landscape of care, education, research and advocacy.
  • We are extremely pleased to have SeaStar Medicals SCD included in the Consensus Statement of ADQI, which builds upon the existing support within the pediatric community for this important therapy.

A global consensus on how to end COVID-19 as a public health threat

Retrieved on: 
Thursday, November 3, 2022
Lazarus, Investor, Public health, NEW, Delphi, Industry, Government, CUNY, Decision-making, Vaccination, Graduate Center, CUNY, COVID-19, Adoption, Infection, Vaccine, Vaccine hesitancy, Health policy, Health, Disease, Goal, CUNY Graduate School of Public Health & Health Policy, NGO, Animal, Nature

NEW YORK, Nov. 3, 2022 /PRNewswire/ -- While significant scientific and medical advances have been made in the fight against COVID-19, the virus remains a major public health threat. The global response has been fraught with challenges such as widespread misinformation about the disease and vaccines, vaccine hesitancy, and inequitable access to treatments and vaccines. Each country has responded differently, and often inadequately, revealing a worrisome lack of coordination and clear goals.

Key Points: 
  • Each country has responded differently, and often inadequately, revealing a worrisome lack of coordination and clear goals.
  • The 57 recommendations encompass six major areas to address this public health threat: communications, health systems, vaccination, prevention, treatment and care, and inequities.
  • The experts emphasize the need for significant efforts to improve health communications, rebuild public trust, combat misinformation, and engage communities directly in the management of this and future public health emergency responses.
  • "With this consensus, we make unique, practical proposals to end COVID-19 as a public health threat now and lay a solid groundwork to address large-scale outbreaks of infectious disease, reducing the burden on society, especially vulnerable populations, over time."

LUNA LAUNCHES COMMUNITY DRIVEN INNOVATION™

Retrieved on: 
Thursday, November 3, 2022
Bias, Woman, Institutional review board, Migraine, SAN, Solution, Association, Epilepsy Foundation, Headache, CDI, Time, Cognitive Function Scanner, Veteran, IRB, Research, American Public Health Association, Patient, Public health, Health, Delphi, Role, PXE, Goal, ISCB Senior Scientist Award, Multimedia, Genomics, Risk management, Pharmaceutical industry

CDI addresses long-standing problems with traditional research approaches by eliminating groupthink bias, reducing cost and time -- especially associated with focus group approaches -- and delivering outputs that can seamlessly flow into studies and clinical trials with fewer or eliminated subsequent approval steps by an Institutional Review Board (IRB). Additionally, the methodology's iterative process is designed for longitudinal data capture so steps can be reinitiated as experiences and environments change over time.

Key Points: 
  • SAN DIEGO, Nov. 3, 2022 /PRNewswire/ -- LunaPBC today announced the launch of Community Driven Innovation (CDI), a participant-centered methodology that improves upon techniques like Delphi, design thinking, and social choice theory to deliver -- in weeks versus years -- an unbiased understanding of group priorities, a hierarchy of values, and pain points.
  • Luna and collaborators will be discussing the impact of CDI as a tool for listening to and engaging with patient communities during several talks at the annual meeting of the American Public Health Association Nov. 6-9.
  • Additionally, the methodology's iterative process is designed for longitudinal data capture so steps can be reinitiated as experiences and environments change over time.
  • Luna makes research representative of the real world and aligned with people's true goals by giving all participants a role from right where they are.

BorgWarner Recognized as a Finalist in Ragan's Prestigious PR Daily Awards

Retrieved on: 
Monday, October 31, 2022
BorgWarner, Delphi, U.S. Securities and Exchange Commission, Multimedia, Annual report, Private Securities Litigation Reform Act, Social media, Publication, EST, Failure, Forward-looking statement, Program, Risk, Marketing communications, Industry, Taco Bell, Marketing, Motor vehicle, Delphi Technologies, Company, Security (finance), Intelligence, OEM, Growth, Acquisition, EV, Public relations, News, Form 10-K, Forward, Perception, COVID-19, Forecasting, Estimates, Information, Goal, Pandemic, PR, Organization, Risk management

AUBURN HILLS, Mich., Oct. 31, 2022 /PRNewswire/ -- BorgWarner has been named as a finalist in Ragan's PR Daily Awards in the re-branding and re-positioning category.

Key Points: 
  • AUBURN HILLS, Mich., Oct. 31, 2022 /PRNewswire/ -- BorgWarner has been named as a finalist in Ragan's PR Daily Awards in the re-branding and re-positioning category.
  • Ragan's PR Daily Awards showcases the top communications campaigns, events, initiatives, publications and more that were instrumental in the success of organizations and clients.
  • "BorgWarner is honored to be named a finalist in Ragan's PR Daily Awards.
  • The program will also feature Matt Prince, Head of Marketing Communications and PR for Taco Bell, as its guest presenter.

BorgWarner's iDM Powers a Leading Chinese Automobile Manufacturer, Creating Better Driving Experience

Retrieved on: 
Thursday, October 27, 2022
U.S. Securities and Exchange Commission, Growth, Goal, Acquisition, BorgWarner, Forward-looking statement, Private Securities Litigation Reform Act, Motor vehicle, Industry, COVID-19, General manager, Delphi, Company, EV, Partnership, Information, Delphi Technologies, OEM, Multimedia, Forecasting, Risk, Semiconductor, Perception, Tax, PLC, IDM, Estimates, Security (finance), Renewable energy, Risk management, Viperidae

This marks the first time that BorgWarner will supply its iDM for a P4 hybrid architecture to this automobile manufacturer.

Key Points: 
  • This marks the first time that BorgWarner will supply its iDM for a P4 hybrid architecture to this automobile manufacturer.
  • "We are pleased to extend our long-standing partnership with this leading Chinese domestic automobile manufacturer by supplying them with our industry leading iDM," said Dr. Stefan Demmerle, President and General Manager, BorgWarner PowerDrive Systems.
  • "We are excited that BorgWarner's high quality and reliable integrated electric drive products are once again recognized by our customers in China.
  • BorgWarner will continue to build on its extensive experience in electric vehicles to provide a better driving experience for our OEM customers."